What this means
Researchers mixed a plant extract with a copper peptide and tested it on skin cells in a dish. The mix lowered inflammation signals linked to atopic dermatitis and helped cells move to close wounds. This does not show it helps people, since only cells were studied.
Plain-English summary written by an AI model from the abstract. The original is below.
- Who it was tested in
- Human skin cells in a lab dish
- Kind of research
- A study
The science
- Original title
- A Torilis japonica Extract-GHK-Cu Complex Attenuates Th2 Cytokines and Promotes Keratinocyte Recovery: A Potential Antioxidant Strategy for Atopic Dermatitis.
- Authors
- Jeon S, Maeng J, Lee J et al.
- Journal
- Antioxidants (Basel, Switzerland)
- Published
- Jul 28, 2026
- Study type
- Study
- PMID
- 42510549 ↗
Abstract
Atopic dermatitis (AD) is a chronic skin disorder driven by Th2 immune dysregulation, persistent inflammation, and epidermal barrier defects. Oxidative stress acts as a major upstream factor in this process, amplifying inflammatory signals and worsening disease severity. While current treatments relieve acute symptoms, long-term application is often constrained by side effects and poor barrier restoration, pointing to a need for safer, multifaceted alternatives. Here, we formulated a complex of Torilis japonica extract (TJE) and GHK-Cu (Glycyl-L-histidyl-L-lysine copper(II)) complex and examined its anti-atopic and skin-regenerative properties using a TNF-α (Tumor necrosis factor-α)/IFN-γ (Interferon-γ)-stimulated HaCaT cell model. TJE decreased the expression of AD-related chemokines (TARC(Thymus and activation-regulated chemokine (CCL17)) and CTACK(Cutaneous T-cell-attracting chemokine (CCL27)) as well as IgE production, confirming the suppression of Th2-driven inflammation. An optimized 6:4 ratio (TJE:GHK-Cu) yielded the highest efficacy compared to individual treatments, indicating a synergistic interaction. TJE-GHK-Cu complex suppressed the transcription of key Th2 cytokines (IL-4, IL-5, IL-10, and IL-13) and promoted keratinocyte migration during wound healing assays. The formulation also displayed strong radical scavenging activity without compromising cell viability. These results demonstrate that the TJE-GHK-Cu complex provides simultaneous anti-inflammatory, antioxidant, and regenerative benefits, presenting a formulation warranting further investigation for managing AD.
Jeon S, Maeng J, Lee J et al. A Torilis japonica Extract-GHK-Cu Complex Attenuates Th2 Cytokines and Promotes Keratinocyte Recovery: A Potential Antioxidant Strategy for Atopic Dermatitis. Antioxidants (Basel, Switzerland). 2026. doi:10.3390/antiox15070818. PMID: 42510549. https://pubmed.ncbi.nlm.nih.gov/42510549/
Related research
Review of copper peptide GHK-Cu studies finds many lab results but few human trials
Researchers read 64 studies on GHK-Cu, a copper-linked peptide, and found much lab and animal work. They say well-designed human trials using microneedles are still needed.
A skin mix with GHK-Cu may help wrinkles and skin barrier in tests
Researchers tested a mix of a ferment extract and a copper peptide for skin aging. The results suggest it may help, but these early tests do not prove it works for everyone.
Review of a copper peptide used in skin treatments
Researchers reviewed 20 studies on GHK-Cu, a copper peptide, for skin and beauty uses. Most were lab or animal studies, and only two were human trials, so more strong testing is still needed.
Review finds GHK-Cu promising in lab and animal studies but unproven in people
Authors reviewed studies of GHK-Cu, a copper-peptide, across labs, animals, small human tests, and drug-delivery work. They say it is not yet a proven treatment for people.
See all research on GHK-Cu (copper peptide) →